Myocardial Protection by Salvia Miltiorrhiza Injection in Streptozotocin-Induced Diabetic Rats through Attenuation of Expression of Thrombospondin-1 and Transforming Growth Factor-β1

Abstract

OBJECTIVES: To investigate the myocardially protective effects of Salvia miltiorrhiza injection in streptozotocin-induced diabetic rats and the possible mechanisms involved. METHODS: Adult male Sprague—Dawley rats were randomized into three groups (n = 10 per group): diabetes, no treatment (Sm-); diabetes, S. miltiorrhiza injection (Sm+); control (no diabetes; saline treatment). After model induction and 4 weeks' treatment, heart function of five rats from each group was tested by Langendorff isolated in vivo heart perfusion. In the remaining rats, pathological changes of the myocardium were observed by haematoxylin and eosin staining, and protein levels of thrombospondin-1 (TSP-1) and transforming growth factor-β1 (TGF-β1) were assessed by immunohistochemistry. RESULTS: Left ventricular systolic end pressure and left ventricular developed pressure were significantly improved in the Sm+ group compared with the Sm- group. Pathological changes were ameliorated through significantly reduced TSP-1 and TGF-β1 protein levels. CONCLUSIONS: S. miltiorrhiza injection may improve the heart function of diabetic rats and protect against cardiomyopathy by downregulating TSP-1 and TGF-β1 in myocardial tissue.

Keywords

SALVIA MILTIORRHIZA DIABETIC CARDIOMYOPATHY HEART FUNCTION THROMBOSPONDIN-1 TRANSFORMING GROWTH FACTOR-β1

References

Young

Lin

Von Korff

: Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care 2008; 14: 15–23.

Singh

Dhingra

Ramdath

: Risk factors preceding type 2 diabetes and cardiomyopathy. J Cardiovasc Transl Res 2010; 3: 580–596.

Tarquini

Lazzeri

Pala

: The diabetic cardiomyopathy. Acta Diabetol 2011; 48: 173–181.

Rosenkranz

: TGF-β₁ and angiotensin networking in cardiac remodeling. Cardiovasc Res 2004; 63: 423–432.

Bujak

Frangogiannis

: The role of TGF-β signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 2007; 74: 184–195.

Yevdokimova

Wahab

Mason

: Thrombospondin-1 is the key activator of TGF-beta1 in human mesangial cells exposed to high glucose. J Am Soc Nephrol 2001;12: 703–712.

Motegi

Harada

Ohe

: Differential involvement of TGF-β1 in mediating the motogenic effects of TSP-1 on endothelial cells, fibroblasts and oral tumour cells. Exp Cell Res 2008; 314: 2323–2333.

Tang

Zhou

Zhang

: The role of thrombospondin-1-mediated TGF-β1 on collagen type III synthesis induced by high glucose. Mol Cell Biochem 2011; 346: 49–56.

Zhong

Zhang

Miao

: The role of glucose/TSP-1/TGFβ1 signal pathways in diabetic cardiomyopathy. Zhonghua Xin Xue Guan Bing Za Zhi 2006; 34: 217–221 [in Chinese, English abstract].

10.

Zhang

Shen

: Expression changes of thrombospondin-1 and neuropeptide Y in myocardium of STZ-induced rats. Int J Cardiol 2005; 105: 192–197.

11.

Jia

Huang

Zhang

: Is danshen (Salvia miltiorrhiza) dripping pill more effective than isosorbide dinitrate in treating angina pectoris? A systematic review of randomized controlled trials. Int J Cardiol 2012; 157: 330–340.

12.

: Danshen (Chinese medicinal herb) preparations for acute myocardial infarction. Cochrane Database Syst Rev 2008; 2: CD004465.

13.

Tan

Zhu

: Comparison of cardioprotective effects using ramipril and DanShen for the treatment of acute myocardial infarction in rats. Life Sci 2003; 73: 1413–1426.

14.

Zhao

Zhou

: Danshen extracts decrease blood C reactive protein and prevent ischemic stroke recurrence: A controlled pilot study. Phytother Res 2009; 23: 1721–1725.

15.

Zhou

Zuo

Chow

: Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 2005; 45: 1345–1359.

16.

Shen

Cheng

: Simultaneous detection of seven phenolic acids in Danshen injection using HPLC with ultraviolet detector. J Zhejiang Univ Sci B 2008; 9: 728–733.

17.

Qin

: Improved quality evaluation of Radix Salvia miltiorrhiza through simultaneous quantification of seven major active components by high-performance liquid chromatography and principal component analysis. Biomed Chromatogr 2007; 21: 931–939.

18.

Wang

Sha

Lesniak

: Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside-induced free radical formation in vitro and ototoxicity in vivo . Antimicrob Agents Chemother 2003; 47: 1836–1841.

19.

Wang

Bao

: Tanshinone IIA prevents cardiac remodeling through attenuating NAD(P)H oxidase-derived reactive oxygen species production in hypertensive rats. Pharmazie 2011; 66: 517–524.

20.

National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals: Guide for the Care and Use of Laboratory Animals, 8th edn. Washington (DC): National Academies Press (USA); 2011.

21.

Wei

Ong

Smith

Ross

: The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes. Heart Lung Circ 2003; 12: 44–50.

22.

Jung

Lee

Ahn

: Effective isolation of magnesium lithospermate B and its inhibition of aldose reductase and fibronectin on mesangial cell line. Chem Pharm Bull (Tokyo) 2002; 50: 1135–1136.

23.

Qian

Huo

Wang

: Inhibition of glucose-induced vascular endothelial growth factor expression by Salvia miltiorrhiza hydrophilic extract in human microvascular endothelial cells: evidence for mitochondrial oxidative stress. J Ethnopharmacol 2011; 137: 985–991.

24.

Yue

Lee

Chan

: Danshen prevents the occurrence of oxidative stress in the eye and aorta of diabetic rats without affecting the hyperglycemic state. J Ethnopharmacol 2006; 106: 136–141.

25.

Cheng

: Danshen: A versatile Chinese herbal drug for the treatment of coronary heart disease. Int J Cardiol 2006; 113: 437–438.

26.

Rao

Thota

Adapala

: Proteomic analysis in diabetic cardiomyopathy using bioinformatics approach. Bioinform Biol Insights 2008; 2: 1–4.

27.

Asbun

Villarreal

: The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol 2006; 47: 693–700.

28.

Ahamed

Janczak

Wittkowski

: In vitro and in vivo evidence that thrombospondin-1 (TSP-1) contributes to stirring- and shear-dependent activation of platelet-derived TGF-β1. PLoS One 2009; 4: e6608.

29.

Zhong

Zhang

Miao

: Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan. Zhonghua Yi Xue Za Zhi 2006; 86: 232–236 [in Chinese, English abstract].

30.

Tada

Kuboki

Nomura

: High glucose levels enhance TGF-β1- thrombospondin-1 pathway in cultured human mesangial cells via mechanisms dependent on glucose-induced PKC activation. J Diabetes Complications 2001; 15: 193–197.

31.

Yung

Lee

Zhang

: Elevated glucose induction of thrombospondin-1 up-regulates fibronectin synthesis in proximal renal tubular epithelial cells through TGF-β1 dependent and TGF-β1 independent pathways. Nephrol Dial Transplant 2006; 21: 1504–1513.